The evidence leans constructive6 supporting, 0 against, 0 worth knowing
Supporting
trading 65% above its 200-day average
sitting at 94% of its 52-week range, with little overhead supply from trapped buyers
up 182% over twelve months
matches stretched far above trend, which has beaten the market by +0.82 points over 20 sessions across 27,715 past signals
2 of the scans it matches have a positive measured record
4 independent kinds of evidence agree today, which is uncommon
Against
nothing the data supports either way
Worth knowing
nothing the data supports either way
What would change this read: a close below 1,017, its 200-day average; a failure to hold the top of its 52-week range.
Assembled automatically from the figures on this page — the scans matched, their measured record, the filed financials, the derivatives positioning and the peer comparison. It is not a recommendation, no one has spoken to the company, and every claim above can be checked against a number further down this page.
How it has performed
price return over each window, measured against zero
What the scans say today
7 of 47 matched on 2026-08-21
AIMTRON matches 7 of the 47 scans today, across 4 different kinds of evidence. Three or more independent families agreeing is uncommon — it is the same test the shortlist on every page uses.